Abstract: Provided herein are systems and methods for identifying alternative splicing derived cell surface antigens. Also provided are methods and compositions for using the identified cell surface antigens. Further provided are methods, compositions, and systems for diagnosing diseases in a subject using the identified cell surface antigens or treating diseases using the same.
Type:
Application
Filed:
August 27, 2021
Publication date:
August 24, 2023
Applicants:
Envisagenics, Inc., Envisagenics, Inc.
Inventors:
Maria Luisa Pineda, Martin Akerman, Gayatri Arun, Naomi Yudanin, Priyanka Dhingra